Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
K-phos #2 Generic Name & Formulations
Legal Class
Rx
General Description
Potassium acid phosphate 305mg, sodium acid phosphate 700mg; equiv. to potassium 2.3mEq and sodium 5.8mEq; tabs.
Pharmacological Class
Urinary acidifier.
See Also
How Supplied
Tabs—100
Manufacturer
K-phos #2 Indications
Indications
Urinary acidification.
K-phos #2 Dosage and Administration
Adult
1 tab 4 times a day with a full glass of water. If urine very alkaline, 1 tab every 2 hours; max 8 tabs daily.
Children
Not recommended.
K-phos #2 Contraindications
Contraindications
Renal or adrenal insufficiency. Severe hepatic disease. Infected phosphate stones. Hyperphosphatemia. Hyperkalemia (Original).
K-phos #2 Boxed Warnings
Not Applicable
K-phos #2 Warnings/Precautions
Warnings/Precautions
Electrolyte restrictions. Cardiac disease. Hypertension. Edema. Monitor serum electrolytes and for GI obstruction. Discontinue if laxation persists after dosage reduction. Hypoparathyroidism. Osteomalacia. Pancreatitis. Dehydration. Toxemia of pregnancy. Pregnancy (Cat.C). Nursing mothers.
K-phos #2 Pharmacokinetics
See Literature
K-phos #2 Interactions
Interactions
Antagonized by antacids. Hyperkalemia with ACE inhibitors, triamterene, spironolactone, amiloride, potassium supplements. Toxicity with digitalis. Hypernatremia with methyldopa, guanethidine, other antihypertensives, corticotropins, mineralocorticoids.
K-phos #2 Adverse Reactions
Adverse Reactions
Small bowel lesions, laxation, headache, dizziness, hyperacidity, nausea, weakness, confusion, paresthesias, seizures, arrhythmias, shortness of breath, edema.
K-phos #2 Clinical Trials
See Literature
K-phos #2 Note
Not Applicable
K-phos #2 Patient Counseling
See Literature
